1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Clinical and angiographic outcomes
  Overall (n = 36) Type I (n = 14) Type II (n = 16) Type III (n = 6) P Value
Technical success (No.) (%) 29 (80.6) 13 (92.9) 13 (81.3) 3 (50.00) .038
Periprocedural complication (No.) (%) 7 (19.4) 1 (7.1) 3 (18.8) 3 (50.00) .038
 Perforation 2 (5.6) 0 0 2 (33.3) .027
 Dissection 2 (5.6) 0 1 (6.25) 1 (16.7) .145
 Thrombosis 1 (2.8) 1 (7.1) 0 0 .274
 Reperfusion hemorrhage 2 (5.6) 0 2 (12.5) 0 .654
Stroke within 30 days (No.) (%) 6 (16.7) 1 (7.1) 2 (12.5) 3 (50.00) .039
 Ischemic stroke 2 (5.6) 1 (7.1) 0 1 (16.7) .654
 Hemorrhagic stroke 4 (11.1) 0 2 (12.50) 2 (33.3) .034
Death within 30 days (No.) (%) 2 (5.6) 0 2 (12.5) 0 .654
mRS score at 90 days (median) (IQR) 1.00 (1.00–2.00) 1.00 (0.00–2.00) 1.00 (1.00–2.00) 1.00 (1.00–2.00) .218
Clinical follow-up (median) (IQR) (mo) 12.00 (6.00–24.00) 9.00 (6.00–14.25) 24.00 (7.50–34.50) 9.00 (8.00–9.00) .267
Imaging follow-up (median) (IQR) (mo) 12.00 (3.00–12.00) 6.00 (3.00–12.00) 12.00 (3.00–12.00) 24.00 (6.00–24.00) .28
Stroke and death beyond 30 days (No.) (%) 2/27 (7.40) 1/12 (8.33) 1/12 (8.33) 0/3 1
Restenosis (No.) (%) 4/26 (15.38) 1/11 (9.09) 3/12 (25.00) 0/3 .757